about
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Read More
0.35
0.03
(9.38%)
8.0M
XNAS Volume
High volume+gain today
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
BioAtla Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..